Email this article 
Hide
Show all
Article Metrics
Abstract of this article was viewed 157 times | 
PDF Article downloaded 42 times
How to cite
Kumar, P.; Mahantheshappa, S.; Balasubramaniyan, S.; Satyanarayan, N.; Achur, R.
Eur. J. Chem.
2023,
14(1), 30-38.
doi:10.5155/eurjchem.14.1.30-38.2350
Kumar, P.; Mahantheshappa, S.; Balasubramaniyan, S.; Satyanarayan, N.; Achur, R. Quinoline analogue as a potential inhibitor of SARS-CoV-2 main protease: ADMET prediction, molecular docking and dynamics simulation analysis.
Eur. J. Chem.
2023,
14(1), 30-38.
doi:10.5155/eurjchem.14.1.30-38.2350
Kumar, P., Mahantheshappa, S., Balasubramaniyan, S., Satyanarayan, N., & Achur, R.
(2023).
Quinoline analogue as a potential inhibitor of SARS-CoV-2 main protease: ADMET prediction, molecular docking and dynamics simulation analysis.
European Journal of Chemistry, 14(1), 30-38.
doi:10.5155/eurjchem.14.1.30-38.2350
Kumar, Praveen, Santhosha Sangapurada Mahantheshappa, Sakthivel Balasubramaniyan, Nayak Devappa Satyanarayan, & Rajeshwara Achur.
"Quinoline analogue as a potential inhibitor of SARS-CoV-2 main protease: ADMET prediction, molecular docking and dynamics simulation analysis." European Journal of Chemistry [Online], 14.1 (2023): 30-38. Web. 28 May. 2023
Kumar, Praveen, Mahantheshappa, Santhosha, Balasubramaniyan, Sakthivel, Satyanarayan, Nayak, AND Achur, Rajeshwara.
"Quinoline analogue as a potential inhibitor of SARS-CoV-2 main protease: ADMET prediction, molecular docking and dynamics simulation analysis" European Journal of Chemistry [Online], Volume 14 Number 1 (31 March 2023)
The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
Save to Zotero
Save to Mendeley
European Journal of Chemistry 2023, 14(1), 30-38 | doi: https://doi.org/10.5155/eurjchem.14.1.30-38.2350 | Get rights and content
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Authors
This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at http://www.eurjchem.com/index.php/eurjchem/pages/view/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (http://www.eurjchem.com/index.php/eurjchem/pages/view/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).
© Copyright 2010 - 2023 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.